Lara D. Veeken · 2019 · 113 citations · 19 references
Life SciencesImmunologyPathologyAutoimmunityInflammationRheumatologyAutoimmune DiseasesAutoimmune InflammationAutoimmune Rheumatic DiseasesCytokine BiologyInflammatory BiomarkersJuvenile Idiopathic ArthritisBiomarkersDisease Activity MeasurementDisease BiomarkersJuvenile ArthritisS100 Protein ExpressionS100 ProteinsSystemic Disease BiomarkersSystemic Inflammation Markers
OBJECTIVES: Systemic juvenile idiopathic arthritis (sJIA) is a childhood arthritis with features of autoinflammation and high risk of macrophage activation syndrome (MAS). IL-18 has been shown to have key roles in sJIA and MAS. We aimed to examine IL-18 levels in sJIA in relation to disease activity and history of MAS and other disease biomarkers namely S100 proteins and CXCL9. METHODS: Total IL-18, CXCL9 and S100 proteins levels were determined in 40 sJIA patients, and IL-18 levels were compared between patients with regards to disease activity, history of MAS, and other biomarkers. RESULTS: Total IL-18 levels were significantly higher in patients with active sJIA (median 16 499 pg/ml; interquartile range (IQR) 4816-61 839), and remained persistently elevated even in the majority of patients with inactive disease (1164 pg/ml; IQR 587-3444). Patients with history of MAS had significantly higher IL-18 levels (13 380 pg/ml; IQR 4212-62 628) as compared with those without MAS history (956.5 pg/ml; IQR 276.3-4262.5). Total IL-18 performed well with area under the curve of 0.8145 and 0.84 in predicting disease activity and history of MAS, respectively. We observed moderate correlation between IL-18 and CXCL9 (R = 0.56), S100A8/A9 (R = 0.47) and S100A12 (R = 0.46). The correlation was stronger for ferritin (R = 0.74) and overall for those with active disease. CONCLUSION: Total IL-18 levels were elevated in the majority of sJIA patients regardless of clinical features, but were higher in patients with active disease and history of MAS. Change in IL-18 may reflect increased disease activity or development of MAS.
19
Virginia Pascual, Florence Allantaz, Edsel Arce et al. · The Journal of Experimental Medicine · 2005 · 917 citations · Full text
Claudia Bracaglia, Kathy de Graaf, Denise Pires Marafon et al. · Annals of the Rheumatic Diseases · 2016 · 291 citations
Medicine, Immunology, Pathology +17